PMID- 7688216 OWN - NLM STAT- MEDLINE DCOM- 19930901 LR - 20190501 IS - 0264-6021 (Print) IS - 1470-8728 (Electronic) IS - 0264-6021 (Linking) VI - 293 ( Pt 2) IP - Pt 2 DP - 1993 Jul 15 TI - Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations. PG - 443-50 AB - alpha 2-Macroglobulin (alpha 2M) undergoes a major conformational change when reacting with proteinases or primary amines. This conformational change has been referred to as the 'slow' to 'fast' transformation based on the increase in alpha 2M mobility shown by non-denaturing PAGE. Previous studies demonstrated that many cytokines, including transforming growth factor beta 1 (TGF-beta 1) and interleukin-1 beta, bind preferentially or exclusively to alpha 2M which has undergone conformational change. In this study, we demonstrate that platelet-derived growth factor-BB (PDGF-BB) also binds preferentially to conformationally transformed alpha 2M (alpha 2M-methylamine, alpha 2M-trypsin) in vitro. Purified 125I-PDGF-BB-alpha 2M-methylamine complex cleared rapidly from the circulation of mice via the alpha 2M receptor/low-density-lipoprotein-receptor-related protein (alpha 2M-R/LRP). In order to determine whether PDGF-BB or TGF-beta 1 binds to native alpha 2M, we defined the native conformation by lack of interaction with alpha 2M-R/LRP instead of electrophoretic mobility. 125I-PDGF-BB was incubated with 4.3 microM native alpha 2M and 0.47 microM alpha 2M-methylamine. The 125I-PDGF-BB distributed evenly between slow-form and fast-form alpha 2M without shifting the electrophoretic mobility of either species. When the mixed preparation was injected intravenously in mice, 125I-PDGF-BB-fast-form-alpha 2M cleared rapidly and selectively from the circulation; 125I-PDGF-BB which was bound to slow-form alpha 2M was stable in the blood (apparently not recognized by alpha 2M-R/LRP). Therefore, while conformationally transformed alpha 2M binds PDGF-BB preferentially in vitro, non-alpha 2M-R/LRP-recognized alpha 2M binds PDGF-BB as well. Binding of 125I-PDGF-BB and 125I-TGF-beta 1 to alpha 2M was demonstrated in vivo by injecting the free growth factors intravenously into mice. Plasma samples which were subjected to non-denaturing PAGE and autoradiography demonstrated binding of both growth factors exclusively to the slow-form of alpha 2M. Therefore, under normal physiological conditions, native alpha 2M (non-alpha 2M-R/LRP-recognized) is the primary form of the proteinase inhibitor functioning as a carrier of PDGF-BB and TGF-beta 1 in the blood. FAU - Crookston, K P AU - Crookston KP AD - Department of Biochemistry, University of Virginia Health Sciences Center, Charlottesville 22908. FAU - Webb, D J AU - Webb DJ FAU - Lamarre, J AU - Lamarre J FAU - Gonias, S L AU - Gonias SL LA - eng GR - CA-53462/CA/NCI NIH HHS/United States GR - GM 07267/GM/NIGMS NIH HHS/United States GR - HL-02272/HL/NHLBI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (Cross-Linking Reagents) RN - 0 (Iodine Radioisotopes) RN - 0 (Low Density Lipoprotein Receptor-Related Protein-1) RN - 0 (Methylamines) RN - 0 (Platelet-Derived Growth Factor) RN - 0 (Receptors, Immunologic) RN - 0 (Transforming Growth Factor beta) RN - 0 (alpha-Macroglobulins) RN - BSF23SJ79E (methylamine) SB - IM MH - Animals MH - Binding Sites MH - Cross-Linking Reagents MH - Humans MH - Iodine Radioisotopes MH - Low Density Lipoprotein Receptor-Related Protein-1 MH - Methylamines/chemistry/metabolism MH - Mice MH - Platelet-Derived Growth Factor/chemistry/*metabolism MH - Protein Conformation MH - Radioligand Assay MH - Receptors, Immunologic/*metabolism MH - Transforming Growth Factor beta/blood/*metabolism MH - alpha-Macroglobulins/chemistry/*metabolism PMC - PMC1134380 EDAT- 1993/07/15 00:00 MHDA- 1993/07/15 00:01 PMCR- 1993/07/15 CRDT- 1993/07/15 00:00 PHST- 1993/07/15 00:00 [pubmed] PHST- 1993/07/15 00:01 [medline] PHST- 1993/07/15 00:00 [entrez] PHST- 1993/07/15 00:00 [pmc-release] AID - 10.1042/bj2930443 [doi] PST - ppublish SO - Biochem J. 1993 Jul 15;293 ( Pt 2)(Pt 2):443-50. doi: 10.1042/bj2930443.